MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease
暂无分享,去创建一个
M. I. Argyropoulou | M. Argyropoulou | S. Konitsiotis | P. Kosta | S. Markoula | S. Konitsiotis | S. Markoula | P. Kosta | Spyridon Konitsiotis
[1] Wolfhard Semmler,et al. Multiexponential Proton Spin‐Spin Relaxation in MR Imaging of Human Brain Tumors , 1989, Journal of computer assisted tomography.
[2] R. Brooks,et al. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. , 1999, Radiology.
[3] R. A. Knight,et al. ASSESSMENT OF RELATIVE BRAIN IRON CONCENTRATIONS USING T-2-WEIGHTED AND T-2(ASTERISK)-WEIGHTED MRI AT 3-TESLA , 1994 .
[4] F. Ye,et al. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance , 1996, Movement disorders : official journal of the Movement Disorder Society.
[5] M. Skalej,et al. Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.
[6] C D Marsden,et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.
[7] A. Parent,et al. Dopaminergic innervation of human basal ganglia , 2000, Journal of Chemical Neuroanatomy.
[8] P D Griffiths,et al. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. , 2000, Brain : a journal of neurology.
[9] K. Earle. Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. , 1968, Journal of neuropathology and experimental neurology.
[10] G E Santyr,et al. Magnetization transfer effects in multislice MR imaging. , 1993, Magnetic resonance imaging.
[11] G. Bartzokis,et al. In vivo MR evaluation of age-related increases in brain iron. , 1994, AJNR. American journal of neuroradiology.
[12] P. Boesiger,et al. T2 relaxation time in patients with Parkinson's disease , 1993, Neurology.
[13] R M Henkelman,et al. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. , 1993, AJNR. American journal of neuroradiology.
[14] K. Mewes,et al. The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. , 2001, Brain : a journal of neurology.
[15] P Riederer,et al. Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains , 1991, Journal of neurochemistry.
[16] R. Switzer,et al. The regional distribution and cellular localization of iron in the rat brain , 1984, Neuroscience.
[17] D. Calne. The free radical hypothesis in idiopathic parkinsonism: Evidence against it , 1992, Annals of neurology.
[18] G. Percheron,et al. Topographical and cytological localization of iron in rat and monkey brains , 1981, Brain Research.
[19] Joannam . Hill. Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA , 1985, Brain Research.
[20] P. Riederer,et al. Biochemical fundamentals of Parkinson's disease. , 1988, The Mount Sinai journal of medicine, New York.
[21] F A Jolesz,et al. Brain hemorrhage: evaluation with fast spin-echo and conventional dual spin-echo images. , 1992, Radiology.
[22] R I Grossman,et al. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes , 1989, Neurology.
[23] A. Lees,et al. Parkinson's Disease Society Brain Bank, London: overview and research. , 1993, Journal of neural transmission. Supplementum.
[24] I. McKeith,et al. MRI Study of Caudate Nucleus Volume in Parkinson’s Disease with and without Dementia with Lewy Bodies and Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.
[25] P. Boesiger,et al. Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen , 2004, Neuroradiology.
[26] K. Jellinger,et al. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. , 1991, Molecular and chemical neuropathology.
[27] K. Jellinger,et al. Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.
[28] G. Reynolds,et al. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain , 2005, Journal of Neural Transmission.
[29] P. Ryvlin,et al. Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease. , 1995, Archives of neurology.
[30] P. Riederer,et al. Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases? , 1994, Journal of neurochemistry.
[31] R. Ordidge,et al. Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease , 1995, Neurology.
[32] P Z Marmarelis,et al. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. , 1999, Magnetic resonance imaging.
[33] R. Krüger,et al. Genetic analysis of immunomodulating factors in sporadic Parkinson's disease , 2000, Journal of Neural Transmission.
[34] S H Lisanby,et al. Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. , 1993, Journal of neural transmission. Supplementum.
[35] C. Marsden,et al. Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.
[36] O. Hassani,et al. Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states , 1997, Neuroscience.
[37] C. Marsden,et al. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia , 1992 .
[38] Yoshiharu Tamakawa,et al. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. , 2002, AJNR. American journal of neuroradiology.
[39] Peter Riederer,et al. Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.
[40] B. Snow,et al. Criteria for diagnosing Parkinson's disease , 1992, Annals of neurology.
[41] C. Marsden,et al. α‐tocopherol levels in brain are not altered in Parkinson's disease , 1992 .
[42] R A Brooks,et al. Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths. , 1990, Radiology.
[43] S. Fahn. Description of Parkinson's Disease as a Clinical Syndrome , 2003, Annals of the New York Academy of Sciences.